Sector revisions ICON Public Limited Company

Equities

Delayed Nasdaq Other stock markets 21:00:00 16/01/2026 GMT			5-day change	1st Jan Change
182.61 ^USD	+0.03%		+0.68%	+0.21%

01-08	Peace Was Cheaper
01-08	Truist Downgrades ICON PLC to Hold From Buy, Trims Price Target to $222 From $231	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	ICON PUBLIC LIMITED COMPANY							16
	LONZA GROUP AG							23
	IQVIA HOLDINGS INC.							20
	BEONE MEDICINES AG							24
	CELLTRION, INC.							22
	REVOLUTION MEDICINES, INC.							19
	MEDPACE HOLDINGS, INC.							12
	EUROFINS SCIENTIFIC SE							15
	ASCENDIS PHARMA A/S							15
	TEMPUS AI, INC.							12
	IONIS PHARMACEUTICALS, INC.							22
	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.							14
	BIO-TECHNE CORPORATION							12
	QIAGEN N.V.							13
	Average							17
	Weighted average by Cap.							19